Facts for Prelims (FFP)
Source: TH
Context: Australia’s Therapeutic Goods Administration (TGA) issued a medical advisory regarding the potential risk of liver injury associated with the use of medicines and herbal supplements containing turmeric or its active ingredient, curcumin.
- The advisory was prompted by 18 reports of liver problems received by TGA, linked to products containing curcuma longa (turmeric) or curcumin.
- The TGA concluded that there is a “rare risk” of liver injury from taking curcuma longa or curcumin in medicinal forms, particularly for individuals with existing or previous liver issues.
Research from other countries:
- France’s ANSES reported cases of hepatitis linked to turmeric-containing food supplements. Turmeric’s ability to stimulate bile secretion for digestion is noted, making it advisable for those with bile duct disease to avoid it.
Safety Standards:
- The European Food Safety Authority suggests an acceptable daily intake of 180 mg of curcumin for a 60 kg adult, while the WHO/Food and Agricultural Organisation recommends 3 mg/kg of body weight.
About Turmeric:
- Turmeric is a flowering plant, Curcuma longa of the ginger family, it is used as a condiment, dye, drug and cosmetic in addition to its use in religious ceremonies.
- India is a leading producer and exporter of turmeric in the world. India produces 80% of turmeric in the world.
- Turmeric has been studied for its potential health benefits, including anti-inflammatory and antioxidant properties, as well as its role in traditional medicine and cuisine.
